Follow
Molecular subtyping of breast cancers
Breast cancers can be identified by specific molecular subtypes based on gene expression within the cancer cells. The most common genes investigated for molecular subtyping of breast cancer are the estrogen receptor (ER) and progesterone receptor (PR), which are together classified as hormone receptor (HR), and human epidermal growth factor receptor (HER2), a protein that helps breast cancers grow. There are four major subtypes HR+/Her2- , HR-/HER2- (also known as triple negative breast cancer), HR+/HER2+, and HR-/HER2+.
What's Popular in Molecular subtyping of breast cancers
OCT 08, 2020 | 12:00 AM
Changes in transcriptional regulation are thought to be one of the key drivers of carcinogenesis. Although next-generation sequencer revolutionized transcriptome analysis, there are limitati...
SEP 23, 2020 | 10:30 AM
Speaker TBD 10:30–10:50 am PDT Exploring the immune tumor microenvironment of hepatocellular carcinoma with Imaging Mass Cytometry™ 10:50 am–11:10 am PDT Presented By: Won...
OCT 11, 2018 | 10:30 AM
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
OCT 10, 2018 | 1:30 PM
Some Abstract...
OCT 11, 2018 | 10:30 AM
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
OCT 10, 2018 | 1:30 PM
Some Abstract...
